Science News
from research organizations

Engineered protein fragment blocks the AIDS virus from entering cells

Date:
April 2, 2011
Source:
Federation of American Societies for Experimental Biology
Summary:
In what could be a potential breakthrough in the battle against AIDS and a major development in the rational design of new drugs, scientists have engineered a new protein that prevents the virus from entering cells.
Share:
       
FULL STORY

In what could be a potential breakthrough in the battle against AIDS and a major development in the rational design of new drugs, scientists have engineered a new protein that prevents the virus from entering cells. This protein is based on a naturally occurring protein in the body that protects cells from viruses, except the human-made version does not cause inflammation and other side effects at the dosages needed to inhibit AIDS.

This discovery was published in the April 2011 issue of The FASEB Journal.

"This is science fiction made reality. These researchers took a protein apart and removed the portion that causes harm, then stabilized and modified the section that has a therapeutic effect," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "Not only is this good news for people with AIDS, it's good news for all of us as this research paves the way for similar work for many, many other illnesses."

The protein fragment is based on a naturally occurring protein called RANTES, which is part of the body's immune system. RANTES naturally defends the body against HIV/AIDS, but cannot be used as a drug or drug candidate because it has several other biological effects which could cause harmful inflammation. After examining the precise molecular structure of the RANTES protein, the researchers discovered that only a small fragment of the RANTES protein is actually responsible for blocking HIV entry into cells. From there, they dissected the desired section of the RANTES protein and worked to stabilize it without compromising its protective effects.

After several sequential steps of molecular refinement and some virtual modeling, the researchers created a peptide with very high potency against HIV, with possible benefits for treating inflammatory diseases such as arthritis and lupus, as well as the prevention of transplant rejection.

"We're finally able to design smart anti-HIV drugs aimed at the right target. That's because scientists have spent decades figuring out the molecular details of how the virus enters cells, and the exact chemical structures involved," Weissmann added. "As the Renaissance sculptors wrought art from crude marble, today's molecular engineers ... use intelligent design to create life-saving chemical masterpieces."


Story Source:

The above post is reprinted from materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. Lusso, L. Vangelista, R. Cimbro, M. Secchi, F. Sironi, R. Longhi, M. Faiella, O. Maglio, V. Pavone. Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity. The FASEB Journal, 2011; DOI: 10.1096/fj.10-167627

Cite This Page:

Federation of American Societies for Experimental Biology. "Engineered protein fragment blocks the AIDS virus from entering cells." ScienceDaily. ScienceDaily, 2 April 2011. <www.sciencedaily.com/releases/2011/03/110331114847.htm>.
Federation of American Societies for Experimental Biology. (2011, April 2). Engineered protein fragment blocks the AIDS virus from entering cells. ScienceDaily. Retrieved September 2, 2015 from www.sciencedaily.com/releases/2011/03/110331114847.htm
Federation of American Societies for Experimental Biology. "Engineered protein fragment blocks the AIDS virus from entering cells." ScienceDaily. www.sciencedaily.com/releases/2011/03/110331114847.htm (accessed September 2, 2015).

Share This Page: